Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study
Dirk van Lier, Benjamin Deniau, Karine Santos, Oliver Hartmann, Emmanuel Dudoignon, François Depret, Benoit Plaud, Pierre-Francois Laterre, Alexandre Mebazaa, Peter Pickkers
Source: ERJ Open Res, 9 (1) 00342-2022; 10.1183/23120541.00342-2022
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Dirk van Lier, Benjamin Deniau, Karine Santos, Oliver Hartmann, Emmanuel Dudoignon, François Depret, Benoit Plaud, Pierre-Francois Laterre, Alexandre Mebazaa, Peter Pickkers. Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study. ERJ Open Res, 9 (1) 00342-2022; 10.1183/23120541.00342-2022
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|